Use access key #2 to skip to page content.
$4.01 0.39 (10.77%)
10/10/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar 1lenzman (< 20) Submitted: 7/08/07 8:52 PM : Outperform Start Price: $11.95 EXEL Score: -24.23

Over 14 new drugs, mostly related to tumor and cancer treatments. A large number of Big Biopharma companies in pacts with this company. Their scientific approach looks to be extraordinary and successful. It will take time for this to see big returns but the "prognosis" looks good from my science backgrounds point of view.

Report this Post Replies: 0 | Reply

Featured Broker Partners